Literature DB >> 6708977

Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol.

D A Pietro, K A LaBresh, R M Shulman, E D Folland, A F Parisi, A A Sasahara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6708977     DOI： 10.1056/NEJM198404193101606

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 2.  Pulmonary hypertension in children: perioperative management.

Authors:  F A Burrows; J R Klinck; M Rabinovitch; D J Bohn
Journal:  Can Anaesth Soc J       Date:  1986-09

3.  Management of primary pulmonary hypertension.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1985-01

Review 4.  Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

5.  Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.

Authors:  J F Ackroyd
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

Review 6.  Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.

Authors:  J P Kovalchin; A R Mott; K L Rosen; T F Feltes
Journal:  Tex Heart Inst J       Date:  1997

7.  Nitric oxide and pulmonary hypertension.

Authors:  Ji-Yeon Sim
Journal:  Korean J Anesthesiol       Date:  2010-01-31

Review 8.  Drug treatment of primary pulmonary hypertension.

Authors:  A A McLeod; D E Jewitt
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

9.  Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.

Authors:  N S Chan; J McLay; A C Kenmure
Journal:  Br Heart J       Date:  1987-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.